5 assets in Chronic Liver Failure

Therapeutic assets addressing Chronic Liver Failure, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Angiotensin Ii Chronic Liver Failure	University of California, Los Angeles	P4	BB (65)
Noradrenaline Chronic Liver Failure	University of California, Los Angeles	P4	BB (65)
Serostim Chronic Liver Failure	Post Graduate Institute of Medical Education and Research, Chandigarh	P2/3	B (60)
rtx001 Chronic Liver Failure	Resolution Therapeutics Limited	P1/2	CCC (48)
Siplizumab Chronic Liver Failure	Elizabeth C. Verna	P1	C (33)